ARCHIVES

Sustained-Release Leuprolide Under Study In Phase III Trial.

This article is from The Cancer Letter archive.

Vol. 26 No. 26 | June 30, 2000

Download PDF Visit The Full Archive

Related Articles

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

European regulators plan more rigorous rules for accelerated approval in cancer.

November 11, 2005

In Brief: Simone Moves To huntsman Foundation, Golde Names MSK Physician-In-Chief

January 26, 1996

In Brief: Health Chief Defends Cancer Program, Corrects The Record On NCI, NIH Support Of Basic Research

January 24, 1975

Hellman, Suit Awarded ASTRO’s Gold Medals

October 26, 1990

A Conversation With Daniel Masys: Acronym “CABIG” Could Be Eliminated

January 6, 2012